Saving Medicare Through Patient-centered Changes — The Case of Injectables
April 25, 2013 | Hagop M. Kantarjian
Table of Contents
Author(s)
Hagop M. Kantarjian
Nonresident Fellow in Health PolicyBy Jeffrey S. Farroni, Leonard Zwelling, Jorge Cortes and Hagop Kantarjian
Medicare covers the cost of injectable drugs only when they're administered in a hospital or physician's office, but considerations of convenience, cost, and quality all argue for encouraging patients to participate in their own care by allowing self-administration.
Read the full article in The New England Journal of Medicine.